Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

Clinical trial NCT02010242 · COMPLETED

Trial details

NCT number: NCT02010242
Sponsor: Calliditas Therapeutics AB
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus With Diabetic Nephropathy

Start date: 2013-10-01
Primary completion: 2015-02-01
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.